Enhancing mRNA Interactions by Engineering the Arc Protein with Nucleocapsid Domain
Source abstract
Abstract
Activity-regulated cytoskeleton-associated protein (Arc) forms virus-like capsids for mRNA transport between neurons. Unlike HIV-1 Group-specific Antigen (Gag), which uses its Nucleocapsid (NC) domain to bind HIV-1 genomic mRNA, mammalian Arc lacks the NC domain, and their direct mRNA binding interactions remain underexplored. This study examined rat Arc's binding to rat Arc 5' UTR (A5U), HIV-1 5' UTR (H5U), and GFP mRNAs, revealing weak binding with no significant preference. Adding the HIV-1 NC domain to rArc's C-terminus significantly improved binding to H5U, while also showing substantial binding to A5U at about 60% of its H5U level and exhibiting twice the affinity for A5U over GFP mRNA. Importantly, rArc-NC binds 3.4 times more A5U and H5U than GST-NC, indicating that rArc NTD-CA aids mRNA binding by HIV-1 NC. These findings suggest a conserved Gag protein-mRNA interaction mechanism, highlighting the potential for developing mRNA delivery systems that combine endogenous Gag NTD-CA with retroviral NC and UTRs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Research and Splicing · RNA and protein synthesis mechanisms · RNA modifications and cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Robert Frederick Smith School of Chemical and Biomolecular Engineering
Cornell University
Meinig School of Biomedical Engineering
Funding
Division of Chemical, Bioengineering, Environmental, and Transport Systems
References (41)
Show source-provided references
1. 10.1146/annurev.genet.40.110405.09044810.1146/annurev.genet.40.110405.090448 ↗
2. 10.3389/fmicb.2012.0026210.3389/fmicb.2012.00262 ↗
3. 10.1016/S0959-437X(99)00031-310.1016/S0959-437X(99)00031-3 ↗
4. 10.3390/ijms2310584710.3390/ijms23105847 ↗
5. 10.1016/j.tig.2006.09.00610.1016/j.tig.2006.09.006 ↗
6. 10.1016/j.neuron.2015.03.03010.1016/j.neuron.2015.03.030 ↗
7. 10.1016/j.neuron.2006.08.03310.1016/j.neuron.2006.08.033 ↗
8. 10.1016/j.cell.2011.09.03610.1016/j.cell.2011.09.036 ↗
9. 10.1016/j.cell.2010.01.02610.1016/j.cell.2010.01.026 ↗
10. 10.1016/j.neuron.2008.05.02310.1016/j.neuron.2008.05.023 ↗
11. 10.1038/nature1292910.1038/nature12929 ↗
12. 10.1016/j.cell.2017.12.02410.1016/j.cell.2017.12.024 ↗
13. 10.1371/journal.ppat.101193710.1371/journal.ppat.1011937 ↗
14. 10.1089/aid.2011.023010.1089/aid.2011.0230 ↗
15. 10.1128/JVI.73.10.8527-8540.199910.1128/JVI.73.10.8527-8540.1999 ↗
16. 10.1126/science.279.5349.38410.1126/science.279.5349.384 ↗
17. 10.7554/eLife.1466310.7554/eLife.14663 ↗
18. 10.1016/j.str.2019.04.00110.1016/j.str.2019.04.001 ↗
19. 10.1111/febs.1561810.1111/febs.15618 ↗
20. 10.3390/ijms2403270010.3390/ijms24032700 ↗
21. 10.1186/gb-2002-3-3-reviews000410.1186/gb-2002-3-3-reviews0004 ↗
22. 10.1006/jmbi.2000.397910.1006/jmbi.2000.3979 ↗
23. 10.1261/rna.038869.11310.1261/rna.038869.113 ↗
24. 10.1016/j.biochi.2020.09.02410.1016/j.biochi.2020.09.024 ↗
25. 10.1016/j.cell.2017.12.02210.1016/j.cell.2017.12.022 ↗
26. 10.1126/science.abg615510.1126/science.abg6155 ↗
27. 10.1038/s41551-023-01150-x10.1038/s41551-023-01150-x ↗
28. 10.1038/s41586-021-03819-210.1038/s41586-021-03819-2 ↗
29. 10.1038/s41592-022-01488-110.1038/s41592-022-01488-1 ↗
30. 10.1073/pnas.24132029810.1073/pnas.241320298 ↗
31. 10.3390/v1403062210.3390/v14030622 ↗
32. 10.2217/fvl.09.410.2217/fvl.09.4 ↗
33. 10.3390/v1309181910.3390/v13091819 ↗
34. 10.1016/j.chom.2021.07.00610.1016/j.chom.2021.07.006 ↗
35. 10.1042/BJ2014144610.1042/BJ20141446 ↗
36. 10.1093/nar/gkad12410.1093/nar/gkad124 ↗
37. 10.1021/acs.biochem.1c0001210.1021/acs.biochem.1c00012 ↗
38. 10.1006/jmbi.2002.542210.1006/jmbi.2002.5422 ↗
39. 10.1093/nar/gkn18810.1093/nar/gkn188 ↗
40. 10.1007/s00216-019-01996-810.1007/s00216-019-01996-8 ↗
41. 10.1016/j.bios.2008.09.03510.1016/j.bios.2008.09.035 ↗